Literature DB >> 2823151

Elevated c-myc expression facilitates the replication of SV40 DNA in human lymphoma cells.

M Classon1, M Henriksson, J Sümegi, G Klein, M L Hammarskjöld, M L Hammaskjöld.   

Abstract

The v-myc oncogene can induce tumours in haematopoietic, mesenchymal and epithelial tissues. The corresponding c-myc proto-oncogene can contribute to the genesis and/or the progression of an equally wide variety of tumours when activated by retroviral insertions, chromosomal translocations or gene amplification. The c-myc gene product is a DNA-binding, nuclear phosphoprotein that is involved in the control of cell proliferation and possibly in DNA synthesis. The replication of Simian virus 40 (SV40) is a useful model system to study eukaryotic DNA replication as the virus relies almost entirely on cellular DNA replication apparatus. The SV40-based vector, pSVEpR4, replicates poorly in the human BJAB lymphoma line and in most human cells, but replicates well in Burkitt lymphoma lines, which have fused immunoglobulin and c-myc genes, resulting in high c-myc expression. Cotransfection of the BJAB cells with a c-myc-expressing construct (pI4-P6) increased the replication of pSVEpR4 tenfold. Our findings indicate that overexpression of the c-myc gene product allows the replication of SV40 in human lymphoma cells, suggesting that c-myc is involved in the control of replication.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823151     DOI: 10.1038/330272a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  34 in total

1.  Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.

Authors:  H Nakai; T A Storm; M A Kay
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.

Authors:  S Mai; J Hanley-Hyde; G J Rainey; T I Kuschak; J T Paul; T D Littlewood; H Mischak; L M Stevens; D W Henderson; J F Mushinski
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

3.  Two N-myc polypeptides with distinct amino termini encoded by the second and third exons of the gene.

Authors:  T P Mäkelä; K Saksela; K Alitalo
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

4.  Coexpression of human immunodeficiency virus envelope proteins and tat from a single simian virus 40 late replacement vector.

Authors:  D Rekosh; A Nygren; P Flodby; M L Hammarskjöld; H Wigzell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  Interferon gamma abrogates the differentiation block in v-myc-expressing U-937 monoblasts.

Authors:  F Oberg; L G Larsson; R Anton; K Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

6.  Regulation of megakaryocyte phenotype in human erythroleukemia cells.

Authors:  M W Long; C H Heffner; J L Williams; C Peters; E V Prochownik
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

7.  Posttranscriptional regulation of cellular gene expression by the c-myc oncogene.

Authors:  G C Prendergast; M D Cole
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

8.  Constitutive expression of simian virus 40 large T antigen in monkey cells activates their capacity to support polyomavirus replication.

Authors:  W J Tang; W R Folk
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  c-Myc binds to 5' flanking sequence motifs of the dihydrofolate reductase gene in cellular extracts: role in proliferation.

Authors:  S Mai; A Jalava
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

10.  Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells.

Authors:  P J Koskinen; L Sistonen; G Evan; R Morimoto; K Alitalo
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.